Drugs / LAS41003
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01102387 | Feb 2010 → Jul 2011 | candidiasis | Almirall, S.A. | Completed | No outcome recorded |
| Phase 2 | NCT01096472 | Feb → Jun 2010 | tinea pedis | Almirall, S.A. | Completed | No outcome recorded |
| Phase 2 | NCT01020994 | Nov 2009 → Jun 2010 | dermatitis | Almirall, S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAS41003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01102387 ↗ |
| Route | Topical | “Once daily, topically” NCT01020994 ↗ |